{
  "run": {
    "generated_at": "2026-01-04T09:05:31.159477+00:00"
  },
  "patient_vector": [
    0.0,
    0.9,
    0.0,
    0.0,
    0.0,
    0.0,
    0.0
  ],
  "top_10": [
    {
      "nct_id": "NCT02359279",
      "fit": 0.9,
      "primary_moa": "MAPK pathway (ras)",
      "moa_vector": {
        "ddr": 0.0,
        "mapk": 0.9,
        "pi3k": 0.0,
        "vegf": 0.0,
        "her2": 0.0,
        "io": 0.0,
        "efflux": 0.0
      }
    },
    {
      "nct_id": "NCT01091779",
      "fit": 0.9,
      "primary_moa": "MAPK pathway (ras)",
      "moa_vector": {
        "ddr": 0.0,
        "mapk": 0.9,
        "pi3k": 0.0,
        "vegf": 0.0,
        "her2": 0.0,
        "io": 0.0,
        "efflux": 0.0
      }
    },
    {
      "nct_id": "NCT00006379",
      "fit": 0.9,
      "primary_moa": "MAPK pathway (raf)",
      "moa_vector": {
        "ddr": 0.0,
        "mapk": 0.9,
        "pi3k": 0.0,
        "vegf": 0.0,
        "her2": 0.0,
        "io": 0.0,
        "efflux": 0.0
      }
    },
    {
      "nct_id": "NCT06638879",
      "fit": 0.9,
      "primary_moa": "MAPK pathway (raf)",
      "moa_vector": {
        "ddr": 0.0,
        "mapk": 0.9,
        "pi3k": 0.0,
        "vegf": 0.0,
        "her2": 0.0,
        "io": 0.0,
        "efflux": 0.0
      }
    },
    {
      "nct_id": "NCT01979679",
      "fit": 0.9,
      "primary_moa": "MAPK pathway (ras)",
      "moa_vector": {
        "ddr": 0.0,
        "mapk": 0.9,
        "pi3k": 0.0,
        "vegf": 0.0,
        "her2": 0.0,
        "io": 0.0,
        "efflux": 0.0
      }
    },
    {
      "nct_id": "NCT02575079",
      "fit": 0.636396,
      "primary_moa": "DDR pathway (atr)",
      "moa_vector": {
        "ddr": 0.9,
        "mapk": 0.9,
        "pi3k": 0.0,
        "vegf": 0.0,
        "her2": 0.0,
        "io": 0.0,
        "efflux": 0.0
      }
    },
    {
      "nct_id": "NCT06331130",
      "fit": 0.0,
      "primary_moa": "HER2-targeted therapy (Trastuzumab deruxtecan with Zanidatamab)",
      "moa_vector": {
        "ddr": 0.0,
        "mapk": 0.0,
        "pi3k": 0.0,
        "vegf": 0.0,
        "her2": 0.95,
        "io": 0.0,
        "efflux": 0.0
      }
    },
    {
      "nct_id": "NCT04284969",
      "fit": 0.0,
      "primary_moa": "DNA Damage Repair (PARP + ATR inhibitors)",
      "moa_vector": {
        "ddr": 0.95,
        "mapk": 0.0,
        "pi3k": 0.0,
        "vegf": 0.0,
        "her2": 0.0,
        "io": 0.0,
        "efflux": 0.0
      }
    },
    {
      "nct_id": "NCT04001023",
      "fit": 0.0,
      "primary_moa": "DNA Damage Repair (PARP inhibitor Olaparib)",
      "moa_vector": {
        "ddr": 0.9,
        "mapk": 0.0,
        "pi3k": 0.0,
        "vegf": 0.0,
        "her2": 0.0,
        "io": 0.0,
        "efflux": 0.0
      }
    },
    {
      "nct_id": "NCT01000259",
      "fit": 0.0,
      "primary_moa": "VEGF Angiogenesis Inhibition (Bevacizumab)",
      "moa_vector": {
        "ddr": 0.0,
        "mapk": 0.0,
        "pi3k": 0.0,
        "vegf": 0.9,
        "her2": 0.0,
        "io": 0.0,
        "efflux": 0.0
      }
    }
  ],
  "notes": [
    "This is a synthetic edge-case prototype for discrimination testing."
  ]
}